• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成纤维细胞生长因子-23介导肿瘤诱导的低磷性骨软化症:一名反复骨折年轻女性的罕见病例及文献复习

FGF-23 transmitted tumor - induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature.

作者信息

Frank Florian A, Gerber Lukas, Cornelius Alexander, Baumhoer Daniel, Krieg Andreas H

机构信息

Department of Orthopaedic and Trauma Surgery, Kantonsspital Aarau, Tellstrasse 25, Aarau 5001, Switzerland.

Department of Nephrology, Dialysis and Transplantation, Kantonsspital Aarau, Tellstrasse 25, Aarau 5001, Switzerland.

出版信息

J Bone Oncol. 2022 Jan 29;33:100413. doi: 10.1016/j.jbo.2022.100413. eCollection 2022 Apr.

DOI:10.1016/j.jbo.2022.100413
PMID:35169537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8829074/
Abstract

We present a case of tumor-induced osteomalacia (TIO) in a young woman of 22 years. The fibroblast growth factor 23 transmitting tumor in her left foot remained undetected for several years. She suffered several fractures including insufficiency fractures of both femoral necks requiring bilateral proximal femoral nailing. After phosphaturia was diagnosed any known genetic etiology was excluded. Even advanced imaging modalities were unable to detect the clinically silent tumor until an Ga-DOTA-TOC-PET/CT-scan revealed a mass with paraneoplastic activity in the left foot. Complete resection of the tumor proved to cure her condition after 9 years of uncertainty and suffering. Serum phosphate levels returned to normal within days. After presentation of the case report, the current literature on published cases of TIO between 1956 and 2021 is summarized to emphasize the importance of an accurate and early diagnosis. Our case report aims to illustrate that a long latency period of diagnosis may be avoided utilizing the latest imaging techniques to spare affected patients from long treatment of symptoms instead of finding the underlying cause.

摘要

我们报告一例22岁年轻女性的肿瘤诱导性骨软化症(TIO)病例。她左足中分泌成纤维细胞生长因子23的肿瘤多年来一直未被发现。她发生了多次骨折,包括双侧股骨颈的骨质疏松性骨折,需要进行双侧股骨近端髓内钉固定术。在诊断出磷酸盐尿症后,排除了所有已知的遗传病因。即使采用先进的影像学检查方法也未能检测到临床上无症状的肿瘤,直到一次镓-多胺基多羧基-奥曲肽正电子发射断层扫描/计算机断层扫描(Ga-DOTA-TOC-PET/CT)显示左足有一个具有副肿瘤活性的肿块。在经历了9年的不确定性和痛苦之后,肿瘤的完全切除证实治愈了她的疾病。血清磷酸盐水平在数天内恢复正常。在报告该病例后,总结了1956年至2021年间已发表的TIO病例的相关文献,以强调准确早期诊断的重要性。我们的病例报告旨在说明,利用最新的成像技术可以避免较长的诊断潜伏期,使受影响的患者不必长期对症治疗,而是找到潜在病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/58c0361e4d1e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/0b10294f921e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/066f64d1a4ee/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/17c7fa679fd5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/32f93667a8c9/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/58c0361e4d1e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/0b10294f921e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/066f64d1a4ee/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/17c7fa679fd5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/32f93667a8c9/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cdf/8829074/58c0361e4d1e/gr5.jpg

相似文献

1
FGF-23 transmitted tumor - induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature.成纤维细胞生长因子-23介导肿瘤诱导的低磷性骨软化症:一名反复骨折年轻女性的罕见病例及文献复习
J Bone Oncol. 2022 Jan 29;33:100413. doi: 10.1016/j.jbo.2022.100413. eCollection 2022 Apr.
2
68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.68Ga DOTA-TATE PET/CT能够在肿瘤诱导的骨软化症患者中定位肿瘤,而这些患者的111In-奥曲肽SPECT/CT检查结果为阴性。
Bone. 2014 Jul;64:222-7. doi: 10.1016/j.bone.2014.04.016. Epub 2014 Apr 24.
3
Reports of 17 Chinese patients with tumor-induced osteomalacia.17例肿瘤诱导性骨软化症中国患者的报告。
J Bone Miner Metab. 2017 May;35(3):298-307. doi: 10.1007/s00774-016-0756-9. Epub 2016 Apr 16.
4
Diagnostic performance and impact on patient management of Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours.镓- DOTATOC PET/CT 检测骨软化症相关肿瘤的诊断性能及其对患者管理的影响。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1710-1720. doi: 10.1007/s00259-018-3971-x. Epub 2018 Mar 12.
5
Comparison of F-FDG PET/CT and Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描与镓- DOTATATE 正电子发射断层扫描/计算机断层扫描在致佝偻病罪犯肿瘤靶向成像中的比较。
Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11.
6
Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria.伴有正常成纤维细胞生长因子23(FGF23)的肿瘤性骨软化症与特发性高钙尿症。
Cureus. 2022 Jan 3;14(1):e20893. doi: 10.7759/cureus.20893. eCollection 2022 Jan.
7
Tumor-Induced Osteomalacia Localized and Excised After Pregnancy.妊娠后定位并切除的肿瘤性骨软化症
AACE Clin Case Rep. 2021 Jun 18;7(6):363-366. doi: 10.1016/j.aace.2021.06.008. eCollection 2021 Nov-Dec.
8
Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.肿瘤诱导的骨软化症——一种超越疼痛、抑郁的神秘疾病。
Endocr Regul. 2021 Sep 13;55(3):163-168. doi: 10.2478/enr-2021-0017.
9
F-AlF-NOTA-octreotide PET/CT in the localization of tumor-induced osteomalacia: case series and literature review.F-AlF-NOTA-奥曲肽 PET/CT 在肿瘤相关性骨软化症定位中的应用:病例系列和文献复习。
Front Endocrinol (Lausanne). 2024 Jun 3;15:1400751. doi: 10.3389/fendo.2024.1400751. eCollection 2024.
10
[Value of Ga-DOTA-TATE Positron Emission Tomography/Computed Tomography in the Localization of Culprit Tumors Causing Osteomalacia with Negative Tc-HYNIC-TOC Single Photo Emission Computed Tomography].[镓-多柔比星-奥曲肽正电子发射断层扫描/计算机断层扫描在Tc-HYNIC-TOC单光子发射计算机断层扫描阴性的骨软化症致病肿瘤定位中的价值]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018 Dec 20;40(6):757-764. doi: 10.3881/j.issn.1000-503X.10693.

引用本文的文献

1
Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.肿瘤相关性骨软化症的识别、诊断和管理全球指南。
J Intern Med. 2023 Mar;293(3):309-328. doi: 10.1111/joim.13593. Epub 2022 Dec 13.
2
Unusual Presentation and Surgical Treatment of a Phosphaturic Mesenchymal Tumor in a Knee.膝关节磷酸尿性间叶肿瘤的罕见表现及手术治疗
Front Surg. 2022 May 25;9:746623. doi: 10.3389/fsurg.2022.746623. eCollection 2022.

本文引用的文献

1
Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing.回复:布罗索尤单抗治疗肿瘤诱导的骨软化症:好东西还不够多。
J Bone Miner Res. 2021 Dec;36(12):2455-2456. doi: 10.1002/jbmr.4317. Epub 2021 May 24.
2
Burosumab for the Treatment of Tumor-Induced Osteomalacia.骨化三醇治疗肿瘤相关性骨软化症。
J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12.
3
Diagnostic efficiency of Ga-DOTANOC PET/CT in patients with suspected tumour-induced osteomalacia.镓-多他曲(Ga-DOTANOC)PET/CT对疑似肿瘤性骨软化症患者的诊断效能
Eur Radiol. 2021 Apr;31(4):2414-2421. doi: 10.1007/s00330-020-07342-2. Epub 2020 Oct 6.
4
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.一项评估抗 FGF23 抗体布罗索尤单抗在 X 连锁低磷血症成人患者中的疗效的随机、双盲、安慰剂对照、3 期临床试验:第 24 周主要分析。
J Bone Miner Res. 2018 Aug;33(8):1383-1393. doi: 10.1002/jbmr.3475. Epub 2018 Jun 26.
5
Diagnostic performance and impact on patient management of Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours.镓- DOTATOC PET/CT 检测骨软化症相关肿瘤的诊断性能及其对患者管理的影响。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1710-1720. doi: 10.1007/s00259-018-3971-x. Epub 2018 Mar 12.
6
Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.股骨皮质隐匿性磷酸盐尿性间叶性肿瘤致瘤性骨软化症——诊断挑战与临床结局。
Endokrynol Pol. 2018;69(2):205-210. doi: 10.5603/EP.a2018.0016. Epub 2018 Feb 14.
7
Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration.因使用羧基麦芽糖铁导致的基于成纤维细胞生长因子23的严重低磷性骨软化症。
BMJ Case Rep. 2018 Jan 3;2018:bcr-2017-222851. doi: 10.1136/bcr-2017-222851.
8
Selective blood sampling for FGF-23 in tumor-induced osteomalacia.肿瘤诱导性骨软化症中FGF-23的选择性血样采集。
Endocrinol Diabetes Metab Case Rep. 2017 Oct 6;2017. doi: 10.1530/EDM-17-0006. eCollection 2017.
9
Effective localization in tumor-induced osteomalacia using Ga-DOTATOC-PET/CT, venous sampling and 3T-MRI.使用镓-奥曲肽PET/CT、静脉采血和3T-MRI对肿瘤性骨软化症进行有效的定位
Endocrinol Diabetes Metab Case Rep. 2017 Apr 19;2017. doi: 10.1530/EDM-17-0005. eCollection 2017.
10
Iron-induced hypophosphatemia: an emerging complication.铁诱导的低磷血症:一种新出现的并发症。
Curr Opin Nephrol Hypertens. 2017 Jul;26(4):266-275. doi: 10.1097/MNH.0000000000000329.